What question did this study set out to answer?

The study aims to understand how COVID-19 changed health behaviors and care perspectives among COPD patients for better clinical trial design.

A23-13 Introducing the Patient Voice Into COPD Clinical Trial Design: Self-Reported Behaviour Change Post COVID-19

View Full Paper

Ask AI

Bookmark

Authors

Cross-sectional survey explores self-reported behavior changes in COPD patients for trial design, suggesting improved patient engagement.

The study aims to understand how COVID-19 changed health behaviors and care perspectives among COPD patients for better clinical trial design.
Cross-sectional survey conducted among COPD patients in the U.S. from October to December 2024.
Captured data on demographics, healthcare utilization, lifestyle adaptations, and attitudes towards health monitoring.
Thematic analysis was performed on open-ended responses to identify patient priorities and barriers.
81% of respondents were aged ≥65, with increased telemedicine use: 49% began after the pandemic.
60% reported reduced physical activity and 70% described increased anxiety linked to social support loss.
Most respondents (81%) expressed willingness to get vaccinated if research aligns with their experiences.

Lu et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark